Clinical trial Recruiting at 1 site Interventional Ages 40 to 55 Women only

Novel functional snack and perimenopause: does a fibre- and phytochemical-rich bite help symptoms?

Official title: Impact of a Novel Functional Snack on Perimenopausal Symptoms and Well-being: a Randomised, Double-blinded, Placebo-controlled, Crossover Trial

Run by King's College London · NCT07599930 · Data updated 2026-11-12

A daily snack enriched with phytochemicals and fiber is being tested to see if it can reduce perimenopausal symptoms and improve well-being in women aged 40–55 who are not using hormone therapy.

More Gut Microbiota trials

Quick facts

Study typeInterventional
Ages40 Years to 55 Years
SexWomen only
Enrollment20 (estimated)
SponsorKing's College London
Academic / other
Locations1 site (London, London)
StatusRecruiting
StartedApril 24, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 20, 2026
Trial IDNCT07599930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 40–55 with perimenopausal symptoms (Menopause Rating Scale ≥14) not using hormone replacement therapy.

Probably not a fit

Some participants may not experience symptom relief or gut microbiota changes from the snack.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses a double-blind, randomized, placebo-controlled crossover design to compare a functional snack with a low-fiber, low-polyphenol placebo over two 4-week periods, separated by a 4-week washout. Participants will consume the assigned snack twice daily while maintaining usual diet and activity and avoiding other probiotic or polyphenol-rich supplements. Outcomes include menopausal symptoms, mood, stress, sleep, cognition, and quality of life, with gut microbiota as a potential mechanism. In-person visits occur at 0, 4, 8, and 12 weeks, with home sample collection preceding visits.

Why it matters

Potential benefit: If successful, the snack could offer a convenient dietary option to help ease perimenopausal symptoms and improve quality of life.

How similar studies have gone: Previous work in similar areas suggests dietary components can influence menopausal symptoms through gut-related mechanisms, but this exact snack formulation is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 40 to 55
* Score 14 or higher on the Menopause Rating Scale
* For intervention purposes, eligible participants are also required to have a mobile phone and be able to read and speak English.

Exclusion Criteria:

* People who consume more than 15g of fibre a day
* People who consume more than 2 cups of coffee or tea a day
* People who consume more than 4 portions (portion = 80g) of fruits and vegetables a day
* People who do not have any intolerances or allergies to the following:
* Any kinds of nuts including tree nuts, peanuts, hazelnuts and coconuts
* Chia seeds
* Pumpkin seeds
* Sunflower seeds
* Dates
* Gluten
* Dairy
* Oats
* Barley
* Soya
* People who smoke or vape or have smoked or vaped in the last 2 years
* People who consume more than 21 drinks a week or have a history of excess alcohol intake
* People with comorbid conditions that may limit participation in the study, such as a history of an acute cardiovascular event, including coronary artery disease, previous myocardial infarction (heart attack), stroke, peripheral artery disease, diabetes mellitus, chronic kidney disease, metabolic syndrome, malignancies, cardiac arrhythmia, renal failure, cardiac failure, uncontrolled hypertension, cancer or major psychiatric or cognitive problems
* People receiving drug treatment for lipid metabolisms (e.g., statins)
* People with a history of long-term use of medicines known to influence glucose metabolism (e.g., corticosteroids) or aspirin
* People taking antihypertensive drugs
* People who take antibiotics or bacterial agents (Probiotics) within 1 month
* People who take vitamin/dietary supplements within 1 month
* Pregnant women, women ready for pregnancy, and nursing mothers
* cardiac arrhythmia
* renal failure
* heart failure (NYHA II-IV)
* diabetes mellitus
* Malignant disease
* People who have participated in a biomedical study within the past 3 months
* Women who require hormone replacement therapy during the development of the protocol.

Where it's running

  • Metabolic Research Unit (KCL, Waterloo Campus)
    London, London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.